-
1
-
-
84861018546
-
Association of coffee drinking with total and cause-specific mortality
-
Freedman N.D., Park Y., Abnet C.C., et al. Association of coffee drinking with total and cause-specific mortality. NEngl J Med 2012, 366:1891-1904.
-
(2012)
NEngl J Med
, vol.366
, pp. 1891-1904
-
-
Freedman, N.D.1
Park, Y.2
Abnet, C.C.3
-
2
-
-
33745127380
-
Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women's Health Study
-
Andersen L.F., Jacobs D.R., Carlsen M.H., et al. Consumption of coffee is associated with reduced risk of death attributed to inflammatory and cardiovascular diseases in the Iowa Women's Health Study. Am J Clin Nutr 2006, 83:1039-1046.
-
(2006)
Am J Clin Nutr
, vol.83
, pp. 1039-1046
-
-
Andersen, L.F.1
Jacobs, D.R.2
Carlsen, M.H.3
-
3
-
-
84862299929
-
Relationship between coffee consumption and prevalence of metabolic syndrome among Japanese civil servants
-
Matsuura H., Mure K., Nishio N., et al. Relationship between coffee consumption and prevalence of metabolic syndrome among Japanese civil servants. JEpidemiol 2012, 22:160-166.
-
(2012)
JEpidemiol
, vol.22
, pp. 160-166
-
-
Matsuura, H.1
Mure, K.2
Nishio, N.3
-
4
-
-
0027092660
-
Alcohol, smoking, coffee, and cirrhosis
-
Klatsky A.L., Armstrong M.A. Alcohol, smoking, coffee, and cirrhosis. Am J Epidemiol 1992, 136:1248-1257.
-
(1992)
Am J Epidemiol
, vol.136
, pp. 1248-1257
-
-
Klatsky, A.L.1
Armstrong, M.A.2
-
5
-
-
0027274899
-
Unexpected effects of coffee consumption on liver enzymes
-
Casiglia E., Spolaore P., Ginocchio G., et al. Unexpected effects of coffee consumption on liver enzymes. Eur J Epidemiol 1993, 9:293-297.
-
(1993)
Eur J Epidemiol
, vol.9
, pp. 293-297
-
-
Casiglia, E.1
Spolaore, P.2
Ginocchio, G.3
-
6
-
-
0031843679
-
Coffee consumption and decreased serum γ-glutamyltransferase and aminotransferase activities among male alcohol drinkers
-
Tanaka K., Tokunaga S., Kono S., et al. Coffee consumption and decreased serum γ-glutamyltransferase and aminotransferase activities among male alcohol drinkers. Int J Epidemiol 1998, 27:438-443.
-
(1998)
Int J Epidemiol
, vol.27
, pp. 438-443
-
-
Tanaka, K.1
Tokunaga, S.2
Kono, S.3
-
7
-
-
0033968394
-
Effects of coffee consumption against the development of liver dysfunction a 4-year follow-up study of middle-aged Japanese male office workers
-
Nakanishi N., Nakamura K., Suzuki K., et al. Effects of coffee consumption against the development of liver dysfunction a 4-year follow-up study of middle-aged Japanese male office workers. Ind Health 2000, 38:99-102.
-
(2000)
Ind Health
, vol.38
, pp. 99-102
-
-
Nakanishi, N.1
Nakamura, K.2
Suzuki, K.3
-
8
-
-
0034908692
-
Coffee consumption and serum aminotransferases in middle-aged Japanese men
-
Honjo S., Kono S., Coleman M.P., et al. Coffee consumption and serum aminotransferases in middle-aged Japanese men. JClin Epidemiol 2001, 54:823-829.
-
(2001)
JClin Epidemiol
, vol.54
, pp. 823-829
-
-
Honjo, S.1
Kono, S.2
Coleman, M.P.3
-
9
-
-
0038499415
-
Coffee intake and mortality from liver cirrhosis
-
Tverdal A., Skurtveit S. Coffee intake and mortality from liver cirrhosis. Ann Epidemiol 2003, 13:419-423.
-
(2003)
Ann Epidemiol
, vol.13
, pp. 419-423
-
-
Tverdal, A.1
Skurtveit, S.2
-
10
-
-
11144257762
-
Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States
-
Ruhl C.E., Everhart J.E. Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States. Gastroenterology 2005, 128:24-32.
-
(2005)
Gastroenterology
, vol.128
, pp. 24-32
-
-
Ruhl, C.E.1
Everhart, J.E.2
-
11
-
-
73449136857
-
Increased caffeine consumption is associated with reduced hepatic fibrosis
-
Modi A.A., Feld J.J., Park Y., et al. Increased caffeine consumption is associated with reduced hepatic fibrosis. Hepatology 2010, 51:201-209.
-
(2010)
Hepatology
, vol.51
, pp. 201-209
-
-
Modi, A.A.1
Feld, J.J.2
Park, Y.3
-
12
-
-
33750055230
-
Coffee consumption and reduced risk of hepatocellular carcinoma among patients with chronic type C liver disease: a case-control study
-
Ohfuji S., Fukushima W., Tanaka T., et al. Coffee consumption and reduced risk of hepatocellular carcinoma among patients with chronic type C liver disease: a case-control study. Hepatol Res 2006, 36:201-208.
-
(2006)
Hepatol Res
, vol.36
, pp. 201-208
-
-
Ohfuji, S.1
Fukushima, W.2
Tanaka, T.3
-
13
-
-
34548297395
-
Coffee drinking and hepatocellular carcinoma risk: a meta-analysis
-
Bravi F., Bosetti C., Tavani A., et al. Coffee drinking and hepatocellular carcinoma risk: a meta-analysis. Hepatology 2007, 46:430-435.
-
(2007)
Hepatology
, vol.46
, pp. 430-435
-
-
Bravi, F.1
Bosetti, C.2
Tavani, A.3
-
14
-
-
34247633571
-
Coffee consumption and risk of liver cancer: a meta-analysis
-
Larsson S.C., Wolk A. Coffee consumption and risk of liver cancer: a meta-analysis. Gastroenterology 2007, 132:1740-1745.
-
(2007)
Gastroenterology
, vol.132
, pp. 1740-1745
-
-
Larsson, S.C.1
Wolk, A.2
-
15
-
-
84885848163
-
Coffee reduces risk for hepatocellular carcinoma: an updated meta-analysis
-
Bravi F., Bosetti C., Tavani A., et al. Coffee reduces risk for hepatocellular carcinoma: an updated meta-analysis. Clin Gastroenterol Hepatol 2013, 11:1413-1421.
-
(2013)
Clin Gastroenterol Hepatol
, vol.11
, pp. 1413-1421
-
-
Bravi, F.1
Bosetti, C.2
Tavani, A.3
-
16
-
-
72949092282
-
Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C
-
Freedman N.D., Everhart J.E., Lindsay K.L., et al. Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C. Hepatology 2009, 50:1360-1369.
-
(2009)
Hepatology
, vol.50
, pp. 1360-1369
-
-
Freedman, N.D.1
Everhart, J.E.2
Lindsay, K.L.3
-
17
-
-
79956132802
-
Association of caffeine intake and histological features of chronic hepatitis C
-
Costentin C.E., Roudot-Thoraval F., Zafrani E.S., et al. Association of caffeine intake and histological features of chronic hepatitis C. JHepatol 2011, 54:1123-1129.
-
(2011)
JHepatol
, vol.54
, pp. 1123-1129
-
-
Costentin, C.E.1
Roudot-Thoraval, F.2
Zafrani, E.S.3
-
18
-
-
33748117772
-
Insulin resistance and HCV: will new knowledge modify clinical management?
-
Negro F. Insulin resistance and HCV: will new knowledge modify clinical management?. JHepatol 2006, 45:514-519.
-
(2006)
JHepatol
, vol.45
, pp. 514-519
-
-
Negro, F.1
-
19
-
-
21444448910
-
Coffee consumption and risk of type 2 diabetes a systematic review
-
Van Dam R.M., Hu F.B. Coffee consumption and risk of type 2 diabetes a systematic review. JAMA 2005, 294:97-104.
-
(2005)
JAMA
, vol.294
, pp. 97-104
-
-
Van Dam, R.M.1
Hu, F.B.2
-
20
-
-
84857444626
-
Higher serum testosterone is associated with increased risk of advanced hepatitis C-related liver disease in males
-
White D.L., Tavakoli-Tabasi S., Kuzniarek J., et al. Higher serum testosterone is associated with increased risk of advanced hepatitis C-related liver disease in males. Hepatology 2012, 55:759-768.
-
(2012)
Hepatology
, vol.55
, pp. 759-768
-
-
White, D.L.1
Tavakoli-Tabasi, S.2
Kuzniarek, J.3
-
21
-
-
84892484308
-
Many patients with interleukin 28B genotypes associated with response to therapy are ineligible for treatment because of comorbidities
-
Kanwal F., White D.L., Tavakoli-Tabasi S., et al. Many patients with interleukin 28B genotypes associated with response to therapy are ineligible for treatment because of comorbidities. Clin Gastroenterol Hepatol 2014, 12:327-333.
-
(2014)
Clin Gastroenterol Hepatol
, vol.12
, pp. 327-333
-
-
Kanwal, F.1
White, D.L.2
Tavakoli-Tabasi, S.3
-
22
-
-
0042855872
-
International physical activity questionnaire: 12-country reliability and validity
-
Craig C.L., Marshall A.L., Sjöström M., et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003, 35:1381-1395.
-
(2003)
Med Sci Sports Exerc
, vol.35
, pp. 1381-1395
-
-
Craig, C.L.1
Marshall, A.L.2
Sjöström, M.3
-
23
-
-
0037126526
-
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report
-
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
-
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106:3143-3421. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).
-
(2002)
Circulation
, vol.106
, pp. 3143-3421
-
-
-
24
-
-
13844318240
-
Coffee, tea, and caffeine consumption and incidence of colon and rectal cancer
-
Michels K.B., Willett W.C., Fuchs C.S., et al. Coffee, tea, and caffeine consumption and incidence of colon and rectal cancer. JNatl Cancer Inst 2005, 97:282-292.
-
(2005)
JNatl Cancer Inst
, vol.97
, pp. 282-292
-
-
Michels, K.B.1
Willett, W.C.2
Fuchs, C.S.3
-
25
-
-
33645977193
-
The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults
-
Iso H., Date C., Wakai K., et al. The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults. Ann Intern Med 2006, 144:554-562.
-
(2006)
Ann Intern Med
, vol.144
, pp. 554-562
-
-
Iso, H.1
Date, C.2
Wakai, K.3
-
26
-
-
32144439266
-
Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca study
-
Halfon P., Bourliere M., Deydier R., et al. Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca study. Am J Gastroenterol 2006, 101:547-555.
-
(2006)
Am J Gastroenterol
, vol.101
, pp. 547-555
-
-
Halfon, P.1
Bourliere, M.2
Deydier, R.3
-
27
-
-
33749138640
-
Aprospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C
-
Ngo Y., Munteanu M., Messous D., et al. Aprospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C. Clin Chem 2006, 52:1887-1896.
-
(2006)
Clin Chem
, vol.52
, pp. 1887-1896
-
-
Ngo, Y.1
Munteanu, M.2
Messous, D.3
-
28
-
-
34548294614
-
Fibrotest-Actitest: the biochemical marker of liver fibrosis-the Israeli experience
-
Morali G., Maor Y., Klar R., et al. Fibrotest-Actitest: the biochemical marker of liver fibrosis-the Israeli experience. Isr Med Assoc J 2007, 9:588-591.
-
(2007)
Isr Med Assoc J
, vol.9
, pp. 588-591
-
-
Morali, G.1
Maor, Y.2
Klar, R.3
-
29
-
-
0035820265
-
Biochemical markersof liver fibrosis in patients with hepatitis C virus infection: a prospective study
-
Imbert-Bismut F., Ratziu V., Pieroni L., et al. Biochemical markersof liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001, 357:1069-1075.
-
(2001)
Lancet
, vol.357
, pp. 1069-1075
-
-
Imbert-Bismut, F.1
Ratziu, V.2
Pieroni, L.3
-
30
-
-
34047273737
-
The FibroTest value in discriminating between insignificant and significant fibrosis in chronic hepatitis C patients. The Romanian experience
-
Grigorescu M., Rusu M., Neculoiu D., et al. The FibroTest value in discriminating between insignificant and significant fibrosis in chronic hepatitis C patients. The Romanian experience. JGastrointest Liver Dis 2007, 16:31-37.
-
(2007)
JGastrointest Liver Dis
, vol.16
, pp. 31-37
-
-
Grigorescu, M.1
Rusu, M.2
Neculoiu, D.3
-
31
-
-
0036906034
-
Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial
-
Poynard T., Imbert-Bismut F., Ratziu V., et al. Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial. JViral Hepat 2002, 9:128-133.
-
(2002)
JViral Hepat
, vol.9
, pp. 128-133
-
-
Poynard, T.1
Imbert-Bismut, F.2
Ratziu, V.3
-
32
-
-
77955337805
-
ActiTest accuracy for the assessment of histological activity grades in patients with chronic hepatitis C, an overview using Obuchowski measure
-
Poynard T., Munteanu M., Ngo Y., et al. ActiTest accuracy for the assessment of histological activity grades in patients with chronic hepatitis C, an overview using Obuchowski measure. Gastroenterol Clin Biol 2010, 34:388-396.
-
(2010)
Gastroenterol Clin Biol
, vol.34
, pp. 388-396
-
-
Poynard, T.1
Munteanu, M.2
Ngo, Y.3
-
33
-
-
83555168316
-
Caffeine is protective in patients with non-alcoholic fatty liver disease
-
Birerdinc A., Stepanova M., Pawloski L., et al. Caffeine is protective in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2012, 35:76-82.
-
(2012)
Aliment Pharmacol Ther
, vol.35
, pp. 76-82
-
-
Birerdinc, A.1
Stepanova, M.2
Pawloski, L.3
-
34
-
-
84897656243
-
Coffee and non-alcoholic fatty liver disease: brewing evidence for hepatoprotection?
-
Chen S., Teoh N.C., Chitturi S., et al. coffee and non-alcoholic fatty liver disease: brewing evidence for hepatoprotection?. JGastroenterol Hepatol 2014, 29:435-441.
-
(2014)
JGastroenterol Hepatol
, vol.29
, pp. 435-441
-
-
Chen, S.1
Teoh, N.C.2
Chitturi, S.3
-
35
-
-
84901244524
-
Effects of coffee consumption, smoking, and hormones on risk for primary sclerosing cholangitis
-
Andersen I.M., Tengesdal G., Lie B.A., et al. Effects of coffee consumption, smoking, and hormones on risk for primary sclerosing cholangitis. Clin Gastroenterol Hepatol 2014, 12:1019-1028.
-
(2014)
Clin Gastroenterol Hepatol
, vol.12
, pp. 1019-1028
-
-
Andersen, I.M.1
Tengesdal, G.2
Lie, B.A.3
-
36
-
-
84906790686
-
Reduced coffee consumption among individuals with primary sclerosing cholangitis but not primary biliary cirrhosis
-
Lammert C., Juran B.D., Schlicht E., et al. Reduced coffee consumption among individuals with primary sclerosing cholangitis but not primary biliary cirrhosis. Clin Gastroenterol Hepatol 2014, 12:1562-1568.
-
(2014)
Clin Gastroenterol Hepatol
, vol.12
, pp. 1562-1568
-
-
Lammert, C.1
Juran, B.D.2
Schlicht, E.3
-
37
-
-
0028674080
-
The effect of drinking coffee and smoking cigarettes on the risk of cirrhosis associated with alcohol consumption. A case-control study
-
Corrao G., Lepore A.R., Torchio P., et al. The effect of drinking coffee and smoking cigarettes on the risk of cirrhosis associated with alcohol consumption. A case-control study. Eur J Epidemiol 1994, 10:657-664.
-
(1994)
Eur J Epidemiol
, vol.10
, pp. 657-664
-
-
Corrao, G.1
Lepore, A.R.2
Torchio, P.3
-
38
-
-
33745038932
-
Coffee, cirrhosis, and transaminase enzymes
-
Klatsky A.L., Morton C., Udaltsova, et al. Coffee, cirrhosis, and transaminase enzymes. Arch Intern Med 2006, 166:1190-1195.
-
(2006)
Arch Intern Med
, vol.166
, pp. 1190-1195
-
-
Klatsky, A.L.1
Morton, C.2
Udaltsova3
-
39
-
-
79959767330
-
Dietary history and physical activity and risk of advanced liver disease in veterans with chronic hepatitis C infection
-
White D.L., Richardson P.A., Al-Saadi M., et al. Dietary history and physical activity and risk of advanced liver disease in veterans with chronic hepatitis C infection. Dig Dis Sci 2011, 56:1835-1847.
-
(2011)
Dig Dis Sci
, vol.56
, pp. 1835-1847
-
-
White, D.L.1
Richardson, P.A.2
Al-Saadi, M.3
-
40
-
-
84897618433
-
Coffee has hepatoprotective benefits in Brazilian patients with chronic hepatitis C even in lower daily consumption than in American and European populations
-
Machado S.R., Parise E.R., de Carvalho L. Coffee has hepatoprotective benefits in Brazilian patients with chronic hepatitis C even in lower daily consumption than in American and European populations. Braz J Infect Dis 2014, 18:170-176.
-
(2014)
Braz J Infect Dis
, vol.18
, pp. 170-176
-
-
Machado, S.R.1
Parise, E.R.2
de Carvalho, L.3
-
41
-
-
84906789794
-
Coffee: a panacea or snake oil for the liver?
-
Kumari R., Kim W.R. Coffee: a panacea or snake oil for the liver?. Clin Gasteroenterol Hepatol 2014, 12:1569-1571.
-
(2014)
Clin Gasteroenterol Hepatol
, vol.12
, pp. 1569-1571
-
-
Kumari, R.1
Kim, W.R.2
-
42
-
-
46749091223
-
Ecto-5'-nucleotidase (CD73)-mediated extracellular adenosine production plays a critical role in hepatic fibrosis
-
Peng Z., Fernandez P., Wilder T., et al. Ecto-5'-nucleotidase (CD73)-mediated extracellular adenosine production plays a critical role in hepatic fibrosis. FASEB J 2008, 22:2263-2272.
-
(2008)
FASEB J
, vol.22
, pp. 2263-2272
-
-
Peng, Z.1
Fernandez, P.2
Wilder, T.3
-
43
-
-
84880699422
-
Coffee attenuates fibrosis by decreasing the expression of TGF-β and CTGF in a murine model of liver damage
-
Arauz J., Moreno M.G., Cortes-Reynosa P., et al. Coffee attenuates fibrosis by decreasing the expression of TGF-β and CTGF in a murine model of liver damage. JAppl Toxicol 2013, 33:970-979.
-
(2013)
JAppl Toxicol
, vol.33
, pp. 970-979
-
-
Arauz, J.1
Moreno, M.G.2
Cortes-Reynosa, P.3
-
44
-
-
53249092406
-
Pharmacological application of caffeine inhibits TGF-beta-stimulated connective tissue growth factor expression in hepatocytes via PPARgamma and SMAD2/3-dependent pathways
-
Gressner O.A., Lahme B., Rehbein K., et al. Pharmacological application of caffeine inhibits TGF-beta-stimulated connective tissue growth factor expression in hepatocytes via PPARgamma and SMAD2/3-dependent pathways. J Hepatol 2008, 49:758-767.
-
(2008)
J Hepatol
, vol.49
, pp. 758-767
-
-
Gressner, O.A.1
Lahme, B.2
Rehbein, K.3
-
45
-
-
50049122662
-
Decreased expression of cytochromes P450 1A2, 2E1, and 3A4 and drug transporters Na+-taurocholate-cotransporting polypeptide, organic cation transporter 1, and organic anion-transporting peptide-C correlates with the progression of liver fibrosis in chronic hepatitis C patients
-
Nakai K., Tanaka H., Hanada K., et al. Decreased expression of cytochromes P450 1A2, 2E1, and 3A4 and drug transporters Na+-taurocholate-cotransporting polypeptide, organic cation transporter 1, and organic anion-transporting peptide-C correlates with the progression of liver fibrosis in chronic hepatitis C patients. Drug Metab Dispos 2008, 36:1786-1793.
-
(2008)
Drug Metab Dispos
, vol.36
, pp. 1786-1793
-
-
Nakai, K.1
Tanaka, H.2
Hanada, K.3
-
46
-
-
0029904160
-
Caffeine as an antioxidant: inhibition of lipid peroxidation induced by reactive oxygen species
-
Devasagayam T.P., Kamat J.P., Mohan H., et al. Caffeine as an antioxidant: inhibition of lipid peroxidation induced by reactive oxygen species. Biochim Biophys Acta 1996, 1282:63-70.
-
(1996)
Biochim Biophys Acta
, vol.1282
, pp. 63-70
-
-
Devasagayam, T.P.1
Kamat, J.P.2
Mohan, H.3
-
47
-
-
0036184947
-
Does coffee protect against liver cirrhosis?
-
Gallus S., Tavani A., Negri E., et al. Does coffee protect against liver cirrhosis?. Ann Epidemiol 2002, 12:202-205.
-
(2002)
Ann Epidemiol
, vol.12
, pp. 202-205
-
-
Gallus, S.1
Tavani, A.2
Negri, E.3
-
48
-
-
0033863355
-
Dietary intake and bioavailability of polyphenols
-
Scalbert A., Williamson G. Dietary intake and bioavailability of polyphenols. JNutr 2000, 130(Suppl):2073S-2085S.
-
(2000)
JNutr
, vol.130
, pp. 2073S-2085S
-
-
Scalbert, A.1
Williamson, G.2
-
49
-
-
0036279253
-
Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity
-
Cavin C., Holzhaeuser D., Scharf G., et al. Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. Food Chem Toxicol 2002, 40:1155-1163.
-
(2002)
Food Chem Toxicol
, vol.40
, pp. 1155-1163
-
-
Cavin, C.1
Holzhaeuser, D.2
Scharf, G.3
-
50
-
-
0035717849
-
The coffee components kahweol and cafestol induce gamma-glutamylcysteine synthetase, the rate limiting enzyme of chemoprotective glutathione synthesis, in several organs of the rat
-
Huber W.W., Scharf G., Rossmanith W., et al. The coffee components kahweol and cafestol induce gamma-glutamylcysteine synthetase, the rate limiting enzyme of chemoprotective glutathione synthesis, in several organs of the rat. Arch Toxicol 2002, 75:685-694.
-
(2002)
Arch Toxicol
, vol.75
, pp. 685-694
-
-
Huber, W.W.1
Scharf, G.2
Rossmanith, W.3
-
51
-
-
0034109403
-
Antioxidant ability of caffeine and its metabolites based on the study of oxygen radical absorbing capacity and inhibition of LDL peroxidation
-
Lee C. Antioxidant ability of caffeine and its metabolites based on the study of oxygen radical absorbing capacity and inhibition of LDL peroxidation. Clin Chim Acta 2000, 295:141-154.
-
(2000)
Clin Chim Acta
, vol.295
, pp. 141-154
-
-
Lee, C.1
-
52
-
-
33646529840
-
Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data
-
Leandro G., Mangia A., Hui J., et al. Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data. Gastroenterology 2006, 130:1636-1642.
-
(2006)
Gastroenterology
, vol.130
, pp. 1636-1642
-
-
Leandro, G.1
Mangia, A.2
Hui, J.3
-
53
-
-
21344472982
-
Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C
-
Hézode C., Roudot-Thoraval F., Nguyen S., et al. Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C. Hepatology 2005, 42:63-71.
-
(2005)
Hepatology
, vol.42
, pp. 63-71
-
-
Hézode, C.1
Roudot-Thoraval, F.2
Nguyen, S.3
-
54
-
-
84877111505
-
Dose- and gender-dependent interactions between coffee consumption and serum GGT activity in alcohol consumers
-
Danielsson J., Kangastupa P., Laatikainen T., et al. Dose- and gender-dependent interactions between coffee consumption and serum GGT activity in alcohol consumers. Alcohol Alcohol 2013, 48:303-307.
-
(2013)
Alcohol Alcohol
, vol.48
, pp. 303-307
-
-
Danielsson, J.1
Kangastupa, P.2
Laatikainen, T.3
-
55
-
-
84875128930
-
Gender-dependent histone deacetylases injury may contribute to differences in liver recovery rates of male and female mice
-
Wang Y., Ye F., Ke Q., et al. Gender-dependent histone deacetylases injury may contribute to differences in liver recovery rates of male and female mice. Transplant Proc 2013, 45:463-473.
-
(2013)
Transplant Proc
, vol.45
, pp. 463-473
-
-
Wang, Y.1
Ye, F.2
Ke, Q.3
|